Markers of cardiotoxicity in breast cancer patients
Scherrer-Crosbie, M.
Clinical Advances in Hematology and Oncology H&o 11(1): 41-42
2013
ISSN/ISBN: 1543-0790 PMID: 23416861 Document Number: 664520
Document emailed within 1 workday
Related Documents
Mangkharak, J.; Patanachak, C.; Podhisuwan, K.; Pleehachinda, R. 1997: The evaluation of combined scintimammography and tumor markers in breast cancer patients Anticancer Research 17(3B): 1611-1614MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Long-Term Variability of Bone Turnover Markers in Patients with Non-Metastatic Breast Cancer Clinical Laboratory 48(11-12): 579-582
Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Aleman, B.M.P.; van Leeuwen, F.E. 2015: Hypofractionated adjuvant radiotherapy for breast cancer: no signs of increased risk of cardiotoxicity Nederlands Tijdschrift Voor Geneeskunde 159: A8856
Xing, Y.; Zhao, J.-h.; Wang, T.-s.; Qiao, W.-l.; Che, W.-j. 2009: The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers Zhonghua Zhong Liu Za Zhi 31(2): 129-133
Lantzsch, T.; Hefler, L.; Krause, U.; Kehl, A.; Goepel, C.; Koelbl, H.; Dunst, J.; Lampe, D. 2002: The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer Anticancer Research 22(3): 1925-1928
Koda, M.; Kanczuga-Koda, L.; Reszec, J.; Sulkowska, M.; Famulski, W.; Baltaziak, M.; Kisielewski, W.; Sulkowski, S. 2004: Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer Folia Morphologica 63(3): 337-341
Liu, L.; Liu, Z-zhe.; Liu, Y-ye.; Zheng, Z-dong.; Liang, X-feng.; Han, Y-ling.; Xie, X-dong. 2013: Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 35(12): 936-940
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Bellet, D.; Mlika-Cabanne, N.; Bedenne, L.; Brun, B.; Demeaux, J.L.; Legrand, J.L.; Lorimier, G.; Mignotte, H.; Ollivier, J.M.; Piperno-Neumann, S.; Rinaldi, Y.; Rousset, H.; Rymer, J.C.; Laversin, S. 2001: Serum markers in breast cancer and colorectal cancer (1997) Gynecologie Obstetrique and Fertilite 29(1): 62-63
Altundag, K. 2017: Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab Journal of BUON: Official Journal of the Balkan Union of Oncology 22(3): 801
Volchenko, N.N.; Litvinova, L.V.; Pugachev, K.K.; Shimbireva, I.B.; Kalashnikov, V.V.; Frank, G.A. 1996: Immunomorphologic markers in breast cancer Arkhiv Patologii 58(1): 6-10
Inaji, H.; Komoike, Y.; Motomura, K.; Koyama, H. 2000: Tumor markers in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 140-145
Botsis, D.; Sarandakou, A.; Kassanos, D.; Kontoravdis, A.; Rizos, D.; Protonotariou, E.; Phocas, I.; Creatsas, G. 1999: Breast cancer markers during normal pregnancy Anticancer Research 19(4c): 3539-3541
Ławicki, S.ła.; Mroczko, B.; Szmitkowski, M. 2003: Cytokines as tumor markers in breast cancer Postepy Higieny i Medycyny Doswiadczalnej 57(4): 455-463
Eskelinen, M.; Kataja, V.; Hämäläinen, E.; Kosma, V.M.; Penttilä, I.; Alhava, E. 1997: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer Anticancer Research 17(2b): 1231-1234
Jotti, G.S.; Bombardieri, E. 1990: Circulating tumor markers in breast cancer (review) Anticancer Research 10(1): 253-258
Denkert, C.; Schickling, O.; von Minckwitz, G. 2006: Preoperative chemotherapy in breast cancer and the development of new predictive markers Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 114-123
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82